EGFR and non-small cell lung carcinoma: During the study period, experts independently identified the number of patients treated in the CTIC for prioritized tumors: 13 patients with advanced gastric cancer, 21 with non‐driver non‐small cell lung cancer (NSCLC), 11 with epidermal growth factor receptor (EFGR) NSCLC, and 32 with multiple myeloma.